GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Heryi Pharmaceutical Co Ltd (BJSE:430478) » Definitions » Asset Impairment Charge

Anhui Heryi Pharmaceutical Co (BJSE:430478) Asset Impairment Charge : ¥0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Anhui Heryi Pharmaceutical Co Asset Impairment Charge?

Anhui Heryi Pharmaceutical Co's Asset Impairment Charge for the three months ended in Mar. 2024 was ¥0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.0 Mil.

Anhui Heryi Pharmaceutical Co Asset Impairment Charge Historical Data

The historical data trend for Anhui Heryi Pharmaceutical Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Heryi Pharmaceutical Co Asset Impairment Charge Chart

Anhui Heryi Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Anhui Heryi Pharmaceutical Co Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Anhui Heryi Pharmaceutical Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Anhui Heryi Pharmaceutical Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Anhui Heryi Pharmaceutical Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Heryi Pharmaceutical Co (BJSE:430478) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Heryi Pharmaceutical Co Ltd (BJSE:430478) » Definitions » Asset Impairment Charge
Comparable Companies
BJSE:873167 BJSE:833230 BJSE:833266 BJSE:836433 BJSE:832566 BJSE:430017 SHSE:600530 BJSE:832735 SHSE:603139 SZSE:002433 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Yangcun Industrial Zone, Anhui Province, Tianchang City, CHN, 239304
Website
http://www.heryipharma.com
Anhui Heryi Pharmaceutical Co Ltd engages in research and development, production, and sales of advanced pharmaceutical intermediates, raw materials, and related products. The main product categories include anti-allergy, anti-thrombosis, anti-oxidation, gastric ulcer, anti-virus, antipyretic and analgesic, and ultraviolet absorbent.

Anhui Heryi Pharmaceutical Co (BJSE:430478) Headlines

No Headlines